Armin Heckel

2.9k total citations · 2 hit papers
23 papers, 2.4k citations indexed

About

Armin Heckel is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Armin Heckel has authored 23 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Armin Heckel's work include Drug Transport and Resistance Mechanisms (5 papers), Synthesis and biological activity (3 papers) and TGF-β signaling in diseases (3 papers). Armin Heckel is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Synthesis and biological activity (3 papers) and TGF-β signaling in diseases (3 papers). Armin Heckel collaborates with scholars based in Germany, United States and Austria. Armin Heckel's co-authors include Gisela Schnapp, Gerald J. Roth, Richard W. Cole, Silke Hauf, Jan‐Michael Peters, Jacques Van Meel, Christine L. Zimmer, Conly L. Rieder, Ulrike Tontsch-Grunt and Frank Hilberg and has published in prestigious journals such as The Journal of Cell Biology, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Armin Heckel

22 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore–microtubule attachment and in maintaining the spindle assembly checkpoint

2003 947 citations Silke Hauf, Richard W. Cole et al. The Journal of Cell Biology profile →
BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy

2008 861 citations Frank Hilberg, Gerald J. Roth et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Armin Heckel Germany	11	1.4k	860	705	595	215	23	2.4k
Gerhard Siemeister Germany	32	2.2k 1.6×	488 0.6×	959 1.4×	411 0.7×	430 2.0×	68	3.3k
Gisela Schnapp Germany	19	2.1k 1.5×	928 1.1×	556 0.8×	619 1.0×	114 0.5×	36	3.4k
Spiros Linardopoulos United Kingdom	28	1.7k 1.2×	1.1k 1.3×	1.1k 1.6×	181 0.3×	161 0.7×	71	2.5k
Jung-Sik Kim United States	26	1.5k 1.1×	232 0.3×	596 0.8×	313 0.5×	90 0.4×	45	2.2k
Jennifer L. Stamos United States	14	2.2k 1.6×	260 0.3×	788 1.1×	370 0.6×	566 2.6×	17	3.3k
Jeffrey Ecsedy United States	32	2.0k 1.5×	2.1k 2.4×	1.6k 2.3×	324 0.5×	49 0.2×	71	3.5k
Sheri L. Moores United States	22	1.7k 1.2×	705 0.8×	762 1.1×	395 0.7×	85 0.4×	31	3.2k
Mathias Schmidt Germany	25	1.3k 0.9×	451 0.5×	1.1k 1.5×	274 0.5×	145 0.7×	59	2.2k
Jacqueline M. Mason Canada	17	1.2k 0.9×	442 0.5×	475 0.7×	188 0.3×	89 0.4×	22	1.7k
Christopher J. Molloy United States	29	1.7k 1.2×	332 0.4×	733 1.0×	190 0.3×	227 1.1×	60	2.8k

Countries citing papers authored by Armin Heckel

Since Specialization

Citations

This map shows the geographic impact of Armin Heckel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armin Heckel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armin Heckel more than expected).

Fields of papers citing papers by Armin Heckel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Armin Heckel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armin Heckel. The network helps show where Armin Heckel may publish in the future.

Co-authorship network of co-authors of Armin Heckel

This figure shows the co-authorship network connecting the top 25 collaborators of Armin Heckel. A scholar is included among the top collaborators of Armin Heckel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Armin Heckel. Armin Heckel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Betzemeier, Bodo, et al.. (2023). Discovery and development of BI 1265162, an ENaC inhibitor for the treatment of cystic fibrosis. European Journal of Medicinal Chemistry. 265. 116038–116038. 3 indexed citations

Roth, Gerald J., Armin Heckel, Thorsten Lehmann, et al.. (2015). Design, synthesis and evaluation of MCH receptor 1 antagonists—Part II: Optimization of pyridazines toward reduced phospholipidosis and hERG inhibition. Bioorganic & Medicinal Chemistry Letters. 25(16). 3270–3274. 8 indexed citations

Oost, Thorsten, Armin Heckel, Thorsten Lehmann, et al.. (2015). Design, synthesis and evaluation of MCH receptor 1 antagonists—Part III: Discovery of pre-clinical development candidate BI 186908. Bioorganic & Medicinal Chemistry Letters. 25(16). 3275–3280. 6 indexed citations

Müller, Stephan, Armin Heckel, Thorsten Lehmann, et al.. (2015). Design, synthesis and evaluation of MCH receptor 1 antagonists—Part I: Optimization of HTS hits towards an in vivo efficacious tool compound BI 414. Bioorganic & Medicinal Chemistry Letters. 25(16). 3264–3269. 2 indexed citations

Pautsch, Alexander, Wolfgang Rist, Herbert Nar, et al.. (2013). Crystal Structure of Glucokinase Regulatory Protein. Biochemistry. 52(20). 3523–3531. 37 indexed citations

Baum, Patrick, Ramona Schmid, Carina Ittrich, et al.. (2010). Phenocopy – A Strategy to Qualify Chemical Compounds during Hit-to-Lead and/or Lead Optimization. PLoS ONE. 5(12). e14272–e14272. 33 indexed citations

Hilberg, Frank, Gerald J. Roth, Martin Krššák, et al.. (2008). BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy. Cancer Research. 68(12). 4774–4782. 861 indexed citations breakdown →

Hilberg, Frank, et al.. (2004). 158 BIBF1120 a novel, small molecule triple angiokinase inhibitor: profiling as a clinical candidate for cancer therapy. European Journal of Cancer Supplements. 2(8). 50–50. 5 indexed citations

Hoerer, S., et al.. (2003). Crystal Structure of the Human Liver X Receptor β Ligand-binding Domain in Complex with a Synthetic Agonist. Journal of Molecular Biology. 334(5). 853–861. 58 indexed citations

10.

Hauf, Silke, Richard W. Cole, Christine L. Zimmer, et al.. (2003). The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore–microtubule attachment and in maintaining the spindle assembly checkpoint. The Journal of Cell Biology. 161(2). 281–294. 947 indexed citations breakdown →

11.

Kasimir‐Bauer, Sabine, et al.. (1996). Modulation of multidrug resistance by BIBW22BS in blasts of de novo or relapsed or persistent acute myeloid leukemia ex vivo. Journal of Cancer Research and Clinical Oncology. 122(5). 307–312. 2 indexed citations

12.

Pouliot, Jean‐François, et al.. (1996). BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.. Molecular Pharmacology. 50(3). 482–492. 6 indexed citations

13.

Pinedo, Herbert M., C.M. Kuiper, Carsten R. Lincke, et al.. (1994). Biochemical modulation of ‘classical’ multidrug resistance by BIBW22BS, a potent derivative of dipyridamole. Annals of Oncology. 5(8). 733–739. 10 indexed citations

14.

Heckel, Armin, et al.. (1994). 6,6-Disubstituted hex-5-enoic acid derivatives as combined thromboxane A2 receptor antagonists and synthetase inhibitors. Journal of Medicinal Chemistry. 37(1). 26–39. 29 indexed citations

15.

Bamberger, U., et al.. (1993). BIBW 22, a dipyridamole analogue, acts as a bifunctional modulator on tumor cells by influencing both P-glycoprotein and nucleoside transport.. PubMed. 53(9). 1974–7. 48 indexed citations

16.

Chou, Kuo‐Chen, Armin Heckel, George Némethy, et al.. (1990). Energetics of the structure and chain tilting of antiparallel β‐barrels in proteins. Proteins Structure Function and Bioinformatics. 8(1). 14–22. 21 indexed citations

17.

Heckel, Armin & Wolfgang Pfleiderer. (1986). Pteridine. Teil LXXIX. Synthese, Reaktionen und Photochemie heterocyclischer N,‐Alkylthioamide. Helvetica Chimica Acta. 69(3). 704–707. 7 indexed citations

18.

Heckel, Armin & Wolfgang Pfleiderer. (1986). Pteridine. Teil LXXXII. Synthese und Reaktivität von Lumazin‐7‐sulfensäuren. Helvetica Chimica Acta. 69(5). 1095–1106. 9 indexed citations

19.

Pfleiderer, Wolfgang, et al.. (1984). Oxidation and Reactivity of Thiopteridines. Heterocycles. 21(2). 586–586.

20.

Heckel, Armin & Wolfgang Pfleiderer. (1983). Lumazinesulfenates - a new class of stable sulfenic acids. Tetrahedron Letters. 24(46). 5047–5050. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact